SCHEMBL29779983

SCHEMBL29779983

Cc1ccc(C=CC(=O)N(CC2CCCO2)c2cc[nH]n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 3/20 0.42
▸ ALDH1A1 P00352 7/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ USP2 O75604 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MGLL Q99685 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20772764 1.00 TRPM8 (0.42) TRPM8ALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL20777381 0.91 MGLL (0.44) TRPM8ALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL20773176 0.90 ALDH1A1 (0.52) TRPM8ALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL29779980 0.90 ALDH1A1 (0.52) TRPM8ALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL22074330 0.89 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2LMNAHPGDKMT2A
SCHEMBL22074349 0.86 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAHPGDKMT2A
SCHEMBL29779976 0.84 TRPM8 (0.58) TRPM8ALDH1A1SMN1; SMN2LMNAALOX15
SCHEMBL20772753 0.84 TRPM8 (0.58) TRPM8ALDH1A1SMN1; SMN2LMNAALOX15
SCHEMBL20773013 0.84 RAB9A (0.55) TRPM8ALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL29779988 0.84 RAB9A (0.55) TRPM8ALDH1A1SMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients BASF SE (DE) 2022-09-06 — — US claimed
EP-3675809-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS BASF SE (DE) 2023-09-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434220-B2 Use of physiological cooling active ingredients, and compositions comprising such active ingredients TRPM8, TRPM7, TRPM5 TRPM8 1/4885ALDH1A1 1810/4885SMN1; SMN2 4063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback